News Release

Adjunctive antipsychotics in major depressive disorder

JAMA Psychiatry

Peer-Reviewed Publication

JAMA Network

About The Study: This systematic review and meta-analysis indicates that differences exist between adjunctive atypical antipsychotics in the treatment of major depressive disorder with respect to overall efficacy and acceptability, which should be simultaneously considered. The absence of adequate and well-controlled studies documenting maintenance efficacy of adjunctive atypical antipsychotics in major depressive disorder remains a knowledge gap. 

Corresponding Author: To contact the corresponding author, Roger S. McIntrye, MD, email roger.mcintyre@bcdf.org.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(10.1001/jamapsychiatry.2026.0658)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2026.0658?guestAccessKey=5b9e80c8-b2e8-4629-bac1-1421adf9962c&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050626


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.